James Feuille Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 12 hours ago
James Feuille has an estimated net worth of at least $248.4 million*, as of Sept. 9, 2026. They own 7.1 million shares of CHYM stock. They have sold 535,287 shares of CHYM stock since 2021, for an estimated $5.0 million.
James Feuille $CHYM SEC Form 4 Insider Trading
James Feuille has filed a total of 6 insider trades in $CHYM since 2021. Their most recent trade was a sale of 93,492 shares, made on Sep 10, 2026. Their largest trade was a sale of 161,090 shares, made on Sep 11, 2026. We estimate that they now own 7.1 million shares of $CHYM, worth an estimated $243.5 million.
Insider Trading at $CHYM
There have been a total of 286 insider trades reported at $CHYM since 2021, with 2,250 shares purchased and 28.3 million shares sold. The most active insider traders in $CHYM stock have been Christopher R Britt, Adam B Frankel, and Amine Asmerom. The most recent trade was a sale of 1,965 shares reported by SHAWN T CAROLAN (None), made on Sep 10, 2026.
History of Insider Stock Trades by James Feuille
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CHYM
|
Sale | 93,492 | Sep 10, 2026 | Sept. 14, 2026, 5:51 p.m. |
|
CHYM
|
Sale | 97,308 | Sep 11, 2026 | Sept. 14, 2026, 5:51 p.m. |
|
CHYM
|
Sale | 161,090 | Sep 11, 2026 | Sept. 14, 2026, 5:51 p.m. |
|
CHYM
|
Sale | 7,229 | Dec 16, 2025 | Dec. 18, 2025, 6:45 p.m. |
|
CHYM
|
Sale | 108,435 | Dec 11, 2025 | Dec. 15, 2025, 9:33 p.m. |
|
CHYM
|
Sale | 67,733 | Dec 11, 2025 | Dec. 15, 2025, 9:33 p.m. |
$CHYM Executives and Stock Owners with Insider Trades
-
Christopher R Britt, Chief Executive Officer
-
Adam B Frankel, General Counsel
-
Amine Asmerom, Chief Accounting Officer
-
Ryan A King, Co-Founder
-
Matthew S Newcomb, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.